Skip to main content
AIMD
NASDAQ Life Sciences

10% Owner Sells $99.8K in Ainos, Inc. Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.3
Mkt Cap
$16.409M
52W Low
$1.61
52W High
$4.5
52W Position info
43% above low
Off High info
49% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

AIMD sits 43% above its 52-week low of $1.61 on elevated volume (2.0× avg).

Summary

A 10% owner of Ainos, Inc., Taiwan Carbon Nano Technology Corp, sold $99,806 worth of common stock in an open market transaction.


Key Events · Ownership and Investor Activity · AIMD

  • Significant Stock Sale by 10% Owner

    Taiwan Carbon Nano Technology Corp, a 10% owner of Ainos, Inc., disposed of 46,000 shares of common stock in an open market sale on January 28, 2026, totaling $99,806.

  • Reduced Stake

    Following this transaction, the reporting owner's direct holdings in Ainos, Inc. now stand at 989,925 shares.


Analysis · AIMD · Life Sciences

Taiwan Carbon Nano Technology Corp, a 10% owner of Ainos, Inc., reported an open market sale of common stock valued at $99,806. This transaction, occurring on January 28, 2026, represents a notable disposition for a company of this size. While the footnote indicates the sale was for the reporting person's general operating purposes, a significant sale by a major shareholder can be perceived negatively by the market, especially following a Schedule 13D filing just two days prior on January 27, 2026, which would have updated their beneficial ownership.

How filings like this one have moved

In the 30 days to Sep 16, 2026, 29.6% of the 1725 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AIMD was trading at $2.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.4M. The 52-week trading range was $1.61 to $4.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AIMD - Latest Insights

AIMD
Sep 16, 2026, 11:00 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.37
Real-time Price: $1.35 info
Change: -$0.020 (-1%) info
Market Cap: $9.968M info
AIMD
Sep 14, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.35 info
Change: -$0.150 (-10%) info
Market Cap: $9.968M info
AIMD
Aug 03, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.52
Real-time Price: $1.35 info
Change: -$0.170 (-11%) info
Market Cap: $9.968M info
AIMD
Aug 03, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.49
Real-time Price: $1.35 info
Change: -$0.140 (-9%) info
Market Cap: $9.968M info
AIMD
Jul 24, 2026, 12:16 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.52
Real-time Price: $1.35 info
Change: -$0.165 (-11%) info
Market Cap: $9.968M info